BKV Corp

BKV

Market cap $2.58B

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced the closing of its underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $26.00 per share, which amount includes 900,000 shares issued pursuant to the underwriters' exercise of their option to purchase additional shares. BKV received net proceeds from this offering of approximately $170.3 million after deducting underwriters' discounts and commissions and estimated offering.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced the pricing of its underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $26.00 per share. The total gross proceeds of the offering, before deducting underwriters' discounts and commissions and estimated offering fees and expenses, are $156.0 million. BKV has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares from BKV at the public offeri.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced that it has launched an underwritten public offering of 6,000,000 shares of its common stock. BKV expects to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares from BKV at the public offering price, less underwriting discounts and commissions. BKV intends to use the net proceeds from the offering, together with cash on hand, for the payment of the cash consideration of the purchase pr.

The insider sale was executed under a pre-set Rule 10b5-1 trading plan, a sign of routine activity rather than discretionary timing. Kalnin retains a substantial economic interest through direct and indirect holdings.

BKV (BKV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BKV Corporation ( BKV ) Q3 2025 Earnings Call November 10, 2025 10:00 AM EST Company Participants Michael Hall - Vice President of Investor Relations Christopher Kalnin - CEO & Director Eric Jacobsen - President of Upstream David Tameron - Chief Financial Officer Conference Call Participants Wei Jiang - Barclays Bank PLC, Research Division Michael Furrow - Pickering Energy Partners LP Neal Dingmann - William Blair & Company L.L.C., Research Division Jacob Roberts - Tudor, Pickering, Holt & Co. Securities, LLC, Research Division Presentation Operator Good morning, everyone, and welcome to BKV's Third Quarter 2025 Earnings Conference Call.

BKV (BKV) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to a loss of $0.27 per share a year ago.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV), today reported financial and operational results for the third quarter of 2025, including guidance for the fourth quarter of 2025. Third Quarter 2025 Highlights Net income attributable to BKV of $76.9 million or $0.90 per diluted share Adjusted Net Income of $42.5 million or $0.50 per diluted share Combined Adjusted EBITDAX attributable to BKV of $91.8 million (includes implied proportionate share of Power JV Adjuste.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) and Banpu Power US Corporation (“BPPUS”) today announced that they have entered into a definitive purchase agreement (the “Purchase Agreement”) pursuant to which BKV will acquire from BPPUS one-half of BPPUS' interest in BKV-BPP Power, LLC (“BKV-BPP Power” or the “Power JV”) such that at the closing of the transaction, BKV would own 75% of the limited liability company interests in BKV-BPP Power. This transaction mark.

DENVER--(BUSINESS WIRE)--BKV Corporation (NYSE: BKV) (“BKV” or the “Company”) today announced that it will report its third quarter 2025 operational and financial results before markets open on Monday, November 10, 2025. Management will also host a conference call at 10:00 a.m. ET on Monday, November 10, 2025, to review the third quarter 2025 results. Participants can access the conference call by dialing (877) 407-0779 (US) or (201) 389-0914 (international). To avoid delays, it is recommended.